MedPharm set to launch First-of-Its kind Cannabis-based Clinical Trial in Alzheimer MedPharm Holdings, an acquisition target of Medicine Man Technologies (OTCQX: MDCL), is all set to launch a landmark, double-blind, placebo controlled clinical trial which will evaluate the effect of cannabis on patients with Dementia and...
CV Sciences (OTCQB: CVSI), the manufacturer of PLUSCBD range of hemp-based CBD oils, the #1 selling hemp CBD supplement in North America, announced the signing of a new distribution agreement with Southeastern Grocers, Inc. The agreement will enable the Company to launch its PlusCBD oil...
Amyotrophic Lateral Sclerosis (ALS) or Lou Gehrig’s disease is a progressive neurodegenerative disease, characterized by the atrophy of nerve cells in brain and spinal cord, leading to hardening and scarring in the affected region. As the disease progresses, patients gradually lose the functioning of muscles,...
Sandhoff Disease also referred to as GM2-gangliosidosis Type ll is an autosomal recessive genetic lipid storage disorder that is caused by an abnormal gene for the beta subunit of the hexosaminidase B enzyme. The dysfunction of this gene causes accumulation of lipids called GM2 gangliosides in the...
vTv Therapeutics (NASDAQ: VTVT), a clinical stage biotechnology company, presented additional positive data from a phase 2 Simplici-T1 study in patients with type 1 diabetes (T1D) at the Annual Meeting of the European Association for the Study of Diabetes in Barcelona. The clinical trial is...
Nonalcoholic Steatohepatitis (NASH) is a form of Non-Alcoholic Fatty Liver Disease (NAFLD) and is characterized by the buildup of FAT in the liver. This condition is marked by hepatitis, inflammation, cell damage and fat deposits in the liver. These fat deposits can cause fibrosis of...
Neurotrope Inc, (NASDAQ: NTRP) announced a setback, with Bryostatin, its lead candidate for the treatment of Alzheimer’s, failing to meet its clinical endpoints of its mid-stage study. The Topline results from the confirmatory Phase 2 study of Bryostatin-1, in moderate to severe Alzheimer’s, failed to achieve...
The Cannabis plant has an estimated 113 different compounds, out of which THC and CBD are the two main constituents. These affect the receptors in the brain to alter an individual’s physical and mental state. THC is mainly responsible for the psychoactive effects or the...
Hemp and Marijuana, though used interchangeably, are distinct strains of the Cannabis sativa plant and have different phytochemical uses and composition. Hemp has very low concentrations of THC and is rich in CBD, which results in very negligible psychoactive effects. Hemp is extensively used in industrial...
The growing acceptance of Marijuana and CDB-based products has given birth to various niche industries. There are numerous companies that offer CDB–based products such as oils, topical lotions, bath salts, edibles, aromatherapy, you name it and chances are that there is already someone offering the...
